Evidence map›Paper›PMID 35425597›Full record

ArticleClinical case reports2022

Case of possible encephalopathy following receiving the first dose of Iranian COVID-19Vaccine; COVIran Barakat.

Mohammad Javad Fallahi, Navid Esmaeilzadeh Shahri, Zohre Khodamoradi, Moazameh Meymandi Nia, Faezeh Sehatpour, Laleh Mahmoudi

Abstract readCase Reports
In one paragraph

Article in Clinical case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mohammad Javad FallahiDepartment of internal medicine Shiraz University of Medical Sciences Shiraz Iran.
Navid Esmaeilzadeh ShahriDepartment of Clinical Pharmacy School of Pharmacy Shiraz University of Medical Sciences Shiraz Iran.ORCID https://orcid.org/0000-0002-0388-8856
Zohre KhodamoradiDepartment of internal medicine Shiraz University of Medical Sciences Shiraz Iran.
Moazameh Meymandi NiaDepartment of internal medicine Shiraz University of Medical Sciences Shiraz Iran.
Faezeh SehatpourDepartment of internal medicine Shiraz University of Medical Sciences Shiraz Iran.
Laleh MahmoudiDepartment of Clinical Pharmacy School of Pharmacy Shiraz University of Medical Sciences Shiraz Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report a case of possible encephalopathy after receiving the first dose of Iran's COVIran Barekat vaccine. The patient had no history of neurological or mental illness. Clinical examinations and radiology reports were performed and differential diagnoses were analyzed by the treatment team. Finally, the possible association between vaccination and encephalopathy was concluded.

Indexed as

COVID‐19COVIran Barekatencephalopathyvaccine

Identifiers

PMID35425597
PMCPMC8989018

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.